All Stories

  1. Cardiac evaluation in the armed forces. A statement of the European Association of Preventive Cardiology of the ESC
  2. Functional Capacity Evaluation and Rehabilitation Strategies in Cardiac Amyloidosis: A Comprehensive Review
  3. Protective role of 3-mercaptopyruvate sulfurtransferase (MPST) in the development of metabolic syndrome and vascular inflammation
  4. Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: Unravelling complementary effects on acute myocardial infarction and metabolic syndrome
  5. The future of education in Preventive Cardiology: a statement of the European Association of Preventive Cardiology of the European Society of Cardiology
  6. Ergophysiological evaluation of heart failure patients with reduced ejection fraction undergoing exercise-based cardiac rehabilitation: A systematic review and meta-analysis
  7. Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity
  8. Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin
  9. Comprehensive Analysis of 1-Year-Old Female Apolipoprotein E-Deficient Mice Reveals Advanced Atherosclerosis with Vulnerable Plaque Characteristics
  10. Safety and long-term outcomes of remote cardiac rehabilitation in coronary heart disease patients: A systematic review
  11. PPARδ activation improves cardiac mitochondrial homeostasis in desmin deficient mice but does not alleviate systolic dysfunction
  12. Standardised Exercise Prescription for Patients with Chronic Coronary Syndrome and/or Heart Failure: A Consensus Statement from the EXPERT Working Group
  13. Appropriate exercise prescription in primary and secondary prevention of cardiovascular disease: why this skill remains to be improved among clinicians and healthcare professionals. A call for action from the EXPERT Network
  14. CTH/MPST double ablation results in enhanced vasorelaxation and reduced blood pressure via upregulation of the eNOS/sGC pathway
  15. Neuroendocrine System Adaptation during Consecutive Extrinsic Stimuli: A Pilot Dynamic Study
  16. Cardiopulmonary exercise testing excludes significant disease in patients recovering from COVID-19
  17. Vaccines and variants: an update on cardiopulmonary assessment prior to return to high-hazard occupations following COVID-19
  18. How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology
  19. Epigenetics in the primary and secondary prevention of cardiovascular disease: influence of exercise and nutrition
  20. Effectiveness of Home-Based Cardiac Rehabilitation, Using Wearable Sensors, as a Multicomponent, Cutting-Edge Intervention: A Systematic Review and Meta-Analysis
  21. Space: the final frontier?
  22. Efficacy, efficiency and safety of a cardiac telerehabilitation programme using wearable sensors in patients with coronary heart disease: the TELEWEAR-CR study protocol
  23. Linee guida ESC 2021 per la prevenzione delle malattie cardiovascolari nella pratica clinica elaborate dalla Task Force per la prevenzione delle malattie cardiovascolari nella pratica clinica costituita da rappresentanti della Società Europea di Cardio...
  24. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies Wi...
  25. Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model
  26. Cardiopulmonary assessment prior to returning to high-hazard occupations post-symptomatic COVID-19 infection: a position statement of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology
  27. Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish
  28. The effects of exercise training on cardiac matrix metalloproteinases activity and cardiac function in mice with diabetic cardiomyopathy
  29. Cardiovascular risk in high-hazard occupations: the role of occupational cardiology
  30. The Interplay between Myocardial Fibrosis, Strain Imaging and Collagen Biomarkers in Adults with Repaired Tetralogy of Fallot
  31. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of...
  32. Elucidating Carfilzomib’s Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin
  33. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
  34. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
  35. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology
  36. Myospryn deficiency leads to impaired cardiac structure and function and schizophrenia-associated symptoms
  37. The European Association of Preventive Cardiology Aviation and Occupational Cardiology Task Force
  38. Is ARIS (aerobic/resistance/inspiratory muscle training) the optimal exercise training programme for chronic heart failure patients?
  39. Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress
  40. Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European H...
  41. Future of preventive cardiology: EAPC vision 2020–22
  42. Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European H...
  43. Crosstalk between coagulation and complement activation promotes cardiac dysfunction in arrhythmogenic right ventricular cardiomyopathy
  44. Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era
  45. Cyclic stroke mortality variations follow sunspot patterns
  46. Desmin is essential for the structure and function of the sinoatrial node: implications for increased arrhythmogenesis
  47. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardi...
  48. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators
  49. Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the Secondary Prevention and Rehabilitation Section of ...
  50. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II)
  51. Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase
  52. Correction: Diverse radiofrequency sensitivity and radiofrequency effects of mobile or cordless phone near fields exposure in Drosophila melanogaster
  53. Do we have to reconsider the guidelines for exercise intensity determination in cardiovascular rehabilitation?
  54. Regional differences in exercise training implementation in heart failure: findings from the Exercise Training in Heart Failure (ExTraHF) survey
  55. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose dependent manner: Implications for inotropy
  56. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis
  57. The importance of return to work: How to achieve optimal reintegration in ACS patients
  58. Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure
  59. Cardiovascular Anatomy and Physiology: Basic Principles and Challenges
  60. Amelioration of desmin network defects by αB-crystallin overexpression confers cardioprotection in a mouse model of dilated cardiomyopathy caused by LMNA gene mutation
  61. Molecular mechanisms of Carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of Metformin
  62. Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Associat
  63. Exercise training for chronic heart failure (ExTraMATCH II): Why all data are not equal
  64. Thrombolysis in Acute Lower Limb Ischemia: Review of the Current Literature
  65. Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials
  66. Combined Type III and Type II Endoleaks after Endovascular Aneurysm Repair: Presentation of 2 Cases and a Literature Review
  67. Validation of Exercise Capacity as a Surrogate Endpoint in Exercise-Based Rehabilitation for Heart Failure
  68. Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group
  69. OP91 Individual Participant Data Meta-Analysis Of Exercise Rehabilitation In Heart Failure
  70. Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects
  71. Seeking best practices for cardiac rehabilitation registries in Europe
  72. Opposite effects of catalase and MnSOD ectopic expression on stress induced defects and mortality in the desmin deficient cardiomyopathy model
  73. Corrigendum to “Exercise-based cardiac rehabilitation in twelve European countries: Results of the European Cardiac Rehabilitation Registry” [Int. J. Cardiol. 228 (2017) 58–67]
  74. Impaired calcium homeostasis is associated with sudden cardiac death and arrhythmias in a genetic equivalent mouse model of the human HRC-Ser96Ala variant
  75. The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concep...
  76. Determining exercise training responders through inflammatory status in heart failure
  77. Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule
  78. Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry
  79. Frailty and cardiac rehabilitation: A call to action from the EAPC Cardiac Rehabilitation Section
  80. The Rehabilitation Outcome Study - CROS
  81. Desmin and αB-crystallin interplay in the maintenance of mitochondrial homeostasis and cardiomyocyte survival
  82. A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study
  83. Peptide-Drug Conjugate GnRH-Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth
  84. Hemodynamic effects of high intensity interval training in COPD patients exhibiting exercise-induced dynamic hyperinflation
  85. Elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques: association with p53 activation and disease severity
  86. Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18
  87. Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy
  88. Ischaemic preconditioning preserves antioxidant enzyme activity and reduces cell damage of in vivo rat hearts undergoing acute ischaemia
  89. Challenges in secondary prevention of cardiovascular diseases
  90. 0161: The neuroprotective agent rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction
  91. Diverse Radiofrequency Sensitivity and Radiofrequency Effects of Mobile or Cordless Phone near Fields Exposure in Drosophila melanogaster
  92. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
  93. P687Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy
  94. P637Desmin null mouse as a possible experimental model of arrhythmogenic cardiomyopathy
  95. Cardiac autonomic nervous activity in adults with coarctation of the aorta late after repair
  96. Neurohormones, cytokines, and aortic function in children with repaired coarctation of the aorta
  97. Complement system modulation as a target for treatment of arrhythmogenic right ventricular dysplasia/cardiomyopathy
  98. Neurohormonal activity and vascular properties late after aortic coarctation repair
  99. Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining "Inflammatory" Macrophage Activation
  100. Neurohormonal and cytokine fluctuations following transcatheter closure for an atrial septal defect
  101. Early shear stress signaling on vascular endothelium by a modified partial carotid ligation model
  102. Regulation of adverse remodelling by osteopontin in a genetic heart failure model
  103. Local Hemodynamics and Intimal Hyperplasia at the Venous Side of a Porcine Arteriovenous Shunt
  104. Usefulness of Natriuretic Peptide Levels to Predict Mortality in Adults With Congenital Heart Disease
  105. Heart rate turbulence in adults with repaired tetralogy of Fallot
  106. Carotid Artery Motion Estimation From Sequences of B-Mode Ultrasound Images: Effect of Scanner Settings and Image Normalization
  107. Local hemodynamics and intimal hyperplasia at the venous side of porcine carotid artery - Jugular vein shunt
  108. Desmin mediates TNF-α–induced aggregate formation and intercalated disk reorganization in heart failure
  109. Psychological consequences among adults following the 1999 earthquake in Athens, Greece
  110. Heart transplantation in heart failure: The prognostic importance of body mass index at time of surgery and subsequent weight changes
  111. Assessment of the classification capability of prediction and approximation methods for HRV analysis
  112. Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes
  113. Statin use and survival in patients with chronic heart failure — results from two observational studies with 5200 patients
  114. Extramatch: exercise training meta analysis of trails in chronic heart failure patients: effect of concomitant drug therapy
  115. Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure
  116. Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue
  117. Review: exercise training delays death and hospital admission in chronic heart failure
  118. 498 Impaired cardiopulmonary exercise function late after tetralogy of Fallot repair. Contributory factors
  119. 876-6 Exercise training meta-analysis of trials in chronic heart failure patients (ExTraMATCH)
  120. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)
  121. The relationship between cholesterol and survival in patients with chronic heart failure
  122. Global Impairment of Cardiac Autonomic Nervous Activity Late After the Fontan Operation
  123. 355 Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandin in reflex ventilatory control
  124. Uric Acid and Survival in Chronic Heart Failure: Validation and Application in Metabolic, Functional, and Hemodynamic Staging
  125. Skeletal Muscle Hypothesis in Heart Failure: Potential Triggers of Ergoreflex Stimulation
  126. Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity
  127. Muscle Metaboreflex-Induced Increases in Stroke Volume
  128. Skeletal Muscle Reflex in Heart Failure Patients: Role of Hydrogen
  129. Chemical Mediators of the Muscle Ergoreflex in Chronic Heart Failure: A Putative Role for Prostaglandins in Reflex Ventilatory Control
  130. Lean tissue-adjusted versus body weight-adjusted peak oxygen consumption and mortality prediction in chronic heart failure
  131. Impaired left ventricular filling predicts augmented ventilatory response to exercise in patients with chronic heart failure
  132. Chronic heart failure in the very elderly: Clinical status, survival, and prognostic factors in 188 patients more than 70 years old
  133. HIGH TUMOUR NECROSIS FACTOR-α LEVELS ARE ASSOCIATED WITH EXERCISE INTOLERANCE AND NEUROHORMONAL ACTIVATION IN CHRONIC HEART FAILURE PATIENTS
  134. Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistance
  135. Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance : Marker of Abnormal Cardiorespiratory Reflex Control and Predictor of Poor Prognosis
  136. Body mass index, obesity, and cachexia vs survival in chronic heart failure: Results from the ELITE 2 study Stefan D. Anker, Constantinos H. Davos, Darrel Francis, Robert Segal, Emanuela Santoro, Philip A. Poole-Wilson, Bertram Pitt, Andrew J. S. Coats...
  137. High tumor necrosis factor levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients Mariantonietta Cicoira, Aidan Bolger, Wolfram Doehner, Mathias Rauchhaus, Constantinos Davos, Rakesh Sharma, Faisa...
  138. Hyperleptinemia in chronic heart failure relates to growth hormone binding protein in male patients with and without cardiac cachexia Wolfram Doehner, Mathias Rauchhaus, Karl Egerer, Claus D. Pflaum, Christian J. Strasburger, Constantinos H. Davos, And...
  139. Serum total cholesterol, high-density lipoprotein, and prognosis in patients with chronic heart failure Mathias Rauchhaus, Wolfram Doehner, Constantinos H. Davos, Rakesh Sharma, Aidan Bolger, Heike Gabriel, Michael Kemp, Andrew J. S. Coats, Stefan D. A...
  140. Endotoxin and severity of chronic heart failure Mathias Rauchhaus, Wolfram Doehner, Aidan Bolger, Rakesh Sharma, Hendrik Schmidt, Constantinos Davos, Michael Kemp, Andrew J. S. Coats, Stefan D. Anker. NHLI, Clinical Cardiology, London, United Kingdom, ...
  141. Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
  142. Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts
  143. Carotid Artery Motion Estimation from Sequences of B-mode Ultrasound Images: Effect of Dynamic Range and Persistence